...
机译:Survivin,BAP1和KI-67免疫组化在与反应性间皮增生区分上皮内瘤瘤中的免疫组化
Hiroshima Univ Inst Biomed &
Hlth Sci Dept Pathol Hiroshima 7348551 Japan;
Hiroshima Univ Inst Biomed &
Hlth Sci Dept Pathol Hiroshima 7348551 Japan;
South Valley Univ Fac Vet Med Dept Pathol &
Clin Pathol Qena 83523 Egypt;
Hiroshima Univ Inst Biomed &
Hlth Sci Dept Pathol Hiroshima 7348551 Japan;
Hiroshima Univ Res Ctr Radiat Casualty Med Res Inst Radiat Biol &
Med Dept Surg Oncol Hiroshima;
Hiroshima Univ Res Ctr Radiat Casualty Med Res Inst Radiat Biol &
Med Dept Surg Oncol Hiroshima;
Hiroshima Univ Inst Biomed &
Hlth Sci Dept Pathol Hiroshima 7348551 Japan;
Okayama Rosai Hosp Dept Internal Med Okayama 7028055 Japan;
Hiroshima Univ Inst Biomed &
Hlth Sci Dept Pathol Hiroshima 7348551 Japan;
BAP1; immunohistochemistry; Ki-67; mesothelioma; reactive mesothelial hyperplasia; survivin;
机译:Survivin,BAP1和KI-67免疫组化在与反应性间皮增生区分上皮内瘤瘤中的免疫组化
机译:如免疫组织化学检测到的,高度表达的EZH2与BAP1和MTAP损失组合,可用于区分来自反应性间皮增生的恶性胸膜间皮瘤
机译:使用组织学和免疫组化标记物将胸膜恶性间皮瘤和原位间皮瘤与反应性间皮增生和反应性胸膜纤维化区分开。
机译:SurvivinBAP1和Ki-67免疫组化在区分上皮样间皮瘤和反应性间皮增生中的效用
机译:BAP1,EZH2和Survivin在差异胸膜上皮细胞瘤和反应性间皮增生中的诊断效用:免疫组化研究